Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures (clinicaltrials.gov) - Oct 17, 2026 - P3 | N=154 | Completed | Sponsor: SK Life Science, Inc. | Active, not recruiting ➔ Completed
Trial completion • CNS Disorders • Epilepsy • Pediatrics
|